{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:32:47Z","timestamp":1760099567545},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,8,20]],"date-time":"2004-08-20T00:00:00Z","timestamp":1092960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00198-004-1715-1","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T19:25:50Z","timestamp":1092943550000},"page":"517-525","source":"Crossref","is-referenced-by-count":22,"title":["Significance of Bio-intact PTH(1\u201384) assay in hemodialysis patients"],"prefix":"10.1007","volume":"16","author":[{"given":"Masaaki","family":"Inaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senji","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,8,20]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","volume":"44","author":"Lepage","year":"1998","unstructured":"Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D\u2019Amour P (1998) A non-(1\u201384) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805\u2013809","journal-title":"Clin Chem"},{"key":"CR2","first-page":"3923","volume":"81","author":"Brossard","year":"1996","unstructured":"Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D\u2019Amour P (1996) Accumulation of a non-(1\u201384) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 81:3923\u20133929","journal-title":"J Clin Endocrinol Metab"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinchem\/46.5.697","volume":"46","author":"Brossard","year":"2000","unstructured":"Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, D\u2019Amour P (2000) Influence of glomerular filtration rate on non-(1\u201384) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 46:697\u2013703","journal-title":"Clin Chem"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","volume":"58","author":"Slatopolsky","year":"2000","unstructured":"Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753\u2013761","journal-title":"Kidney Int"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/endo.142.4.8093","volume":"142","author":"Nguyen-Yamamoto","year":"2001","unstructured":"Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, D\u2019Amour P (2001) Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH\/PTH-related peptide receptor. Endocrinology 142:1386-1392","journal-title":"Endocrinology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/en.2002-221026","volume":"144","author":"Langub","year":"2003","unstructured":"Langub MC, Monier-Faugere M-C, Wang G, Williams JP, Koszewski NJ, Malluche HH (2003) Administration of PTH-(7\u201384) antagonizes the effects of PTH-(1\u201384) on bone in rats with moderate renal failure. Endocrinology 144:1135\u20131138","journal-title":"Endocrinology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","volume":"143","author":"Divieti","year":"2002","unstructured":"Divieti P, John MR, Juppner H, Bringhurst FR (2002) Human PTH-(7\u201384) inhibits bone resorption in vitro via actions independent of the type I-PTH\/PTHrP receptor. Endocrinology 143:171\u2013176","journal-title":"Endocrinology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0002-9343(74)90805-5","volume":"56","author":"Segre","year":"1974","unstructured":"Segre GV, Niall HD, Habener JF, Potts JT Jr (1974) Metabolism of parathyroid hormone: physiological and clinical significance. Am J Med 56:774\u2013784","journal-title":"Am J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/eje.0.1470123","volume":"147","author":"Nguyen-Yamamoto","year":"2002","unstructured":"Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, Gao P, Cantor T, D\u2019Amour P (2002) Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays. Eur J Endocrinol 147:123\u2013131","journal-title":"Eur J Endocrinol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/endo-117-1-127","volume":"117","author":"D","year":"1985","unstructured":"D\u2019Armour P, Lazure C (1985) Metabolism of radioiodinated carboxyterminal fragments of bovine parathyroid hormone in normal and anephric rats. Endocrinology 117:127\u2013134","journal-title":"Endocrinology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1210\/endo-104-4-1181","volume":"104","author":"Mayer","year":"1979","unstructured":"Mayer GP, Keaton JA, Hurst JG, Habener JF (1979) Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology 104:1778\u20131784","journal-title":"Endocrinology"},{"key":"CR12","first-page":"58","volume":"16","author":"Watson","year":"1993","unstructured":"Watson PH, Hanley DA (1993) Parathyroid hormone: regulation of synthesis and secretion. Clin Invest Med 16:58\u201377","journal-title":"Clin Invest Med"},{"key":"CR13","first-page":"145","volume":"75","author":"Quarles","year":"1992","unstructured":"Quarles LD, Lobaugh B, Murphy G (1992) Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145\u2013150","journal-title":"J Clin Endocrinol Metab"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1373\/clinchem.2003.026831","volume":"50","author":"Inaba","year":"2004","unstructured":"Inaba M, Nakatuska K, Imanishi Y, Watanabe M, Mamiya Y, Ishimura E, Nishizawa Y (2004) Technical and clinical characterization of the Bio-PTH (1\u201384) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem 50:385\u2013390","journal-title":"Clin Chem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","volume":"84","author":"John","year":"1999","unstructured":"John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Juppner H (1999) A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287\u20134290","journal-title":"J Clin Endocrinol Metab"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","volume":"16","author":"Gao","year":"2001","unstructured":"Gao P, Scheibel S, D\u2019Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL (2001) Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1\u201384: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605\u2013614","journal-title":"J Bone Miner Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1681\/ASN.V1291921","volume":"12","author":"Ishimura","year":"2001","unstructured":"Ishimura E, Okuno S, Kim M, Yamamoto T, Izumotani T, Otoshi T, Shoji T, Inaba M, Nishizawa Y (2001) Increasing body fat mass in the first year of hemodialysis. J Am Soc Nephrol 12:1921\u20131926","journal-title":"J Am Soc Nephrol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/jn\/130.6.1543","volume":"130","author":"Inaba","year":"2000","unstructured":"Inaba M, Morii H, Katsumata T, Goto H, Ishimura E, Kawagishi T, Kamao M, Okano T, Nishizawa Y (2000) Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats. J Nutr 130:1543\u20131547","journal-title":"J Nutr"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s001980050180","volume":"9","author":"Inaba","year":"1999","unstructured":"Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T, Ishmura E, Nakatsuka K, Shioi A, Morii H (1999) Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 9:525\u2013531","journal-title":"Osteoporos Int"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0026-0495(99)90227-5","volume":"48","author":"Inaba","year":"1999","unstructured":"Inaba M, Terada M, Nishizawa Y, Shioi A, Ishimura E, Otani S, Morii H (1999) Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. Metabolism 48:904\u2013909","journal-title":"Metabolism"},{"key":"CR21","first-page":"4157","volume":"85","author":"Kumeda","year":"2000","unstructured":"Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y (2000) Persistent increase in bone turnover in Graves\u2019 patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85:4157\u20134161","journal-title":"J Clin Endocrinol Metab"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","volume":"41","author":"Gomes","year":"1995","unstructured":"Gomes B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41:1560\u20131566","journal-title":"Clin Chem"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0009-8981(99)00251-X","volume":"294","author":"Takahashi","year":"2000","unstructured":"Takahashi M, Kushida K, Nagano A, Inoue T (2000) Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clin Chim Acta 294:67\u201376","journal-title":"Clin Chim Acta"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0753-3322(02)00344-X","volume":"57","author":"Nagasue","year":"2003","unstructured":"Nagasue K, Inaba M, Okuno S, Kitatani K, Imanishi Y, Ishimura E, Miki T, Kim M, Nishizawa Y (2003) Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients. Biomed Pharmacother 57:98\u2013104","journal-title":"Biomed Pharmacother"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/ajkd.2002.35692","volume":"40","author":"Ueda","year":"2002","unstructured":"Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Kim M, Nishizawa Y (2002) Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 40:802\u2013809","journal-title":"Am J Kidney Dis"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/ajkd.2002.33400","volume":"39","author":"Inaba","year":"2002","unstructured":"Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, Shoji T, Ishimura E, Ohta T, Nakatani T, Kim M, Nishizawa Y (2002) Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 39:1261\u20131269","journal-title":"Am J Kidney Dis"},{"key":"CR27","first-page":"64","volume":"27","author":"Furumitsu","year":"2000","unstructured":"Furumitsu Y, Inaba M, Yukioka K, Yukioka M, Kumeda Y, Azuma Y, Ohta T, Ochi T, Nishizawa Y, Morii H (2000) Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis. J Rheumatol 27:64\u201370","journal-title":"J Rheumatol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0009-8981(95)06012-8","volume":"235","author":"Niwa","year":"1995","unstructured":"Niwa T, Shiobara K, Hamada T, Miyazaki T, Tsukushi S, Uema K, Tsuzuki T (1995) Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients. Clin Chim Acta 235:33\u201340","journal-title":"Clin Chim Acta"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/clinchem\/47.8.1410","volume":"47","author":"Okabe","year":"2001","unstructured":"Okabe R, Nakatsuska K, Inaba M, Miki T, Naka H, Masaki H, Moriguchi A, Nishizawa Y (2001) Clinical evaluation of the Elecsys \u03b2-CrossLaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem 47:1410\u20131414","journal-title":"Clin Chem"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00774-003-0460-4","volume":"22","author":"Okabe","year":"2004","unstructured":"Okabe R, Inaba M, Nakatsuka K, Miki T, Naka H, Moriguchi A, Nishizawa Y (2004) Significance of serum CrossLaps as a predictor for changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. J Bone Miner Metab 22:127\u2013131","journal-title":"J Bone Miner Metab"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1053\/ajkd.2001.29254","volume":"38","author":"Avram","year":"2001","unstructured":"Avram MM, Mittman N, Myint MM, Fein P (2001) Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis 38:1351\u20131357","journal-title":"Am J Kidney Dis"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","volume":"63","author":"Salusky","year":"2003","unstructured":"Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Juppner H (2003) Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63:1801\u20131808","journal-title":"Kidney Int"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","volume":"60","author":"Monier-Faugere","year":"2001","unstructured":"Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH (2001) Improved assessment of bone turnover by the PTH-(1\u201384)\/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460\u20131468","journal-title":"Kidney Int"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","volume":"40","author":"Coen","year":"2002","unstructured":"Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F. Manni M, Morosetti M, Moscaritolo E, Sardella (2002) PTH 1\u201384 and PTH \u201c7\u201384\u201d in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:348\u2013354","journal-title":"Am J Kidney Dis"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1715-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-004-1715-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1715-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T03:49:39Z","timestamp":1624592979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-004-1715-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,20]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1715"],"URL":"https:\/\/doi.org\/10.1007\/s00198-004-1715-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,20]]}}}